CC
Cytosorbents Crp
🇺🇸XNAS.CTSOUnited StatesHealthcare
$0.78USDdown -0.03 (-3.7%)ClosedDelayed10:27 PM
Price$0.78-0.03 (-3.7%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23283X2062
- CUSIP
- 58404X107
Company
- Employees
- 129
- Headquarters
- Princeton, United States
- Website
- https://www.cytosorbents.com
- CEO
- Dr. Phillip P. Chan M.D., Ph.D.
Market
- Shares outstanding
- 3.2M
- Market cap
- $48.99M
Highlights
- Market cap
- $48.99M
- EPS LTM
- -$5.80
- P/E LTM
- -0.13calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $37.22M+3.07%up year on year
- Net income
- -$18.21M-86.81%down year on year
- Gross margin
- 71.61%-3.97%down year on year
- Free cash flow
- -$10.42M-1.36%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.